ORIGINAL RESEARCH ARTICLE
1517 -- Antimicrobial Activity of Tigecycline (GAR-936) Against Enterococcus faecium and Staphylococcus aureus Used Alone and in Combination
Renee-Claude Mercier, Pharm.D., Christine Kennedy, Pharm.D., and Christina Meadows, B.A.
BRIEF REPORTS
1524 -- Etiology and Frequency of Rhabdomyolysis
Corri Black, M.B., and Hershel Jick, M.D.
1527 -- Comparison of Gemfibrozil and Fenofibrate in Patients with Dyslipidemic Coronary Heart Disease
Kathleen A. Packard, Pharm.D., James M. Backes, Pharm.D., Thomas L. Lenz, Pharm.D., Richard L. Wurdeman, Pharm.D., Christopher J. Destache, Pharm.D., and Daniel E. Hilleman, Pharm.D.
1533 -- Improving Blood Pressure Control in a Pharmacist-Managed Hypertension Clinic
Eva M. Vivian, Pharm.D.
1541 -- Compliance with National Guidelines in Patients with Diabetes in a Family Practice Clinic
Julienne K. Kirk, Pharm.D., Jessica E. Poirier, B.S., Michelle G. Mattox, Pharm.D., Perry M. Thomas, M.D., and Robert Michielutte, Ph.D.
REVIEWS OF THERAPEUTICS
1547 -- Implications of Amyloid Precursor Protein and Subsequent b-Amyloid Production to the Pharmacotherapy of AlzheimerÕs Disease
Carlos H. Rojas-Fernandez, Pharm.D., Ming Chen, Ph.D., and Hugo L. Fernandez, Ph.D.
1564 -- Prevention of Venous Thromboembolism in Acute Medical Illness
Jason M. Enders, Pharm.D., John M. Burke, Pharm.D., FASHP, FCCP, and Paul P. Dobesh, Pharm.D.
PRACTICE INSIGHTS
1579 -- National Survey of Pharmacist Certified Diabetes Educators
Laura Shane-McWhorter, Pharm.D., FASCP, Joli D. Fermo, Pharm.D., Nanette C. Bultemeier, Pharm.D., and Gary M. Oderda, Pharm.D., M.P.H.
1594 -- Key Articles and Guidelines Relative to Intensive Care Unit Pharmacology
Brian L. Erstad, Pharm.D., FCCM, FCCP, FASHP, Ché J. Jordan, Pharm.D., and Michael C. Thomas, Pharm.D.
1611 -- Evaluation of the Ability of Seven Herbal Resources to Answer Questions About Herbal Products Asked in Drug Information Centers
J. Bryan Walker, Pharm.D.
1616 -- Health-Related Quality of Life in Patients 7 Months After a Myocardial Infarction: Factors Affecting the Short Form-12
Christopher R. McBurney, Pharm.D., Kim A. Eagle, M.D., Eva M. Kline-Rogers, M.S., Jeanna V. Cooper, M.S., Obli C. M. Mani, MBBS, Dean E. Smith, Ph.D., and Steven R. Erickson, Pharm.D.
1623 -- Modeling the Cost-Effectiveness of a Smoking-Cessation Program in a Community Pharmacy Practice
Mongthuong T. Tran, Pharm.D., David A. Holdford, M.S., Ph.D., Daniel T. Kennedy, Pharm.D., and Ralph E. Small, Pharm.D., FAPhA, FCCP
CASE REPORTS
1632 -- Probable Case of Torsades de Pointes Induced by Fluconazole
Minou Khazan, Pharm.D., Ph.D., and A. Scott Mathis, Pharm.D.
1638 -- Thrombotic Complications After Intravenous Immunoglobulin Therapy in Two Patients
Geoffrey G. Emerson, M.D., Ph.D., Christopher N. Herndon, B.S., and Antoine G. Sreih, M.D.
ALTERNATIVE VIEWPOINTS
1642 -- Patient Detection of a Drug Dispensing Error by Use of Physician-Provided Drug Samples
Elizabeth S. Dodds Ashley, Pharm.D., Kevin Kirk, M.D., and Vance G. Fowler, Jr., M.D., M.H.S.
1645 -- Index to Volume 22, 2002, and Acknowledgement of Academic Reviewers for 2002